EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION
                     906 OF THE SARBANES-OXLEY ACT OF 2002



         In connection with the Quarterly Report of Elite Pharmaceuticals,  Inc.
(the  "Company") on Form 10-Q for the quarter ended December 31, 2005 filed with
the Securities and Exchange  Commission  (the  "Report"),  I, Mark I. Gittelman,
Chief Financial  Officer and Treasurer of the Company,  certify,  pursuant to 18
U.S. C. Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that:

        (3) The Report fully complies with the  requirements of Section 13(a) of
        the Securities Exchange Act of 1934; and

        (4) The  information  contained in the Report  fairly  presents,  in all
        material respects,  the consolidated  financial condition of the Company
        as of the dates presented and the  consolidated  result of operations of
        the Company for the periods presented.


                                        /s/ Mark I. Gittelman
Date:    February 14, 2006              ________________________________________
                                        Mark I. Gittelman
                                        Chief Financial Officer and Treasurer of
                                        Elite Pharmaceuticals, Inc.


This  certification  has been  furnished  solely  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

A signed  original of this  written  statement  required by Section 906 has been
provided  to  Elite  Pharmaceuticals,   Inc.  and  will  be  retained  by  Elite
Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.